Johan Wedell-Wedellsborg, Director at Y-mAbs Therapeutics, Inc. (YMAB), sold 22,458 shares at $36.15 ($812K) on 2021-06-10, disclosed to the SEC on 2021-06-11.
Open-market sale of $812k YMAB by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.15 | 11,229 | $406K | 50.0% |
| 2 | $36.15 | 11,229 | $406K | 50.0% |
| Total | $36.15 avg | 22,458 | $812K | 100% |
| Filing → |
| YMAB | BUY | 2023-12-01 | $619K | — | Filing → |
| YMAB | BUY | 2023-11-29 | $1.0M | — | Filing → |
| YMAB | BUY | 2023-05-17 | $982K | — | Filing → |